Shareholders' Equity (Narrative) (Details) - USD ($) $ in Millions |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
|
| Equity [Abstract] | |||
| Common shares, shares authorized (in shares) | 100,000,000 | 100,000,000 | |
| Preferred stock, shares authorized (in shares) | 50,000,000 | 50,000,000 | |
| Total authorizations which remain available for use | $ 55.9 | ||
| Deferred tax (benefit) expense included in OCI | $ (5.0) | $ 9.9 | |
| X | ||||||||||
- Definition The remaining amount authorized by an entity's Board of Directors for stock repurchase or debt repayment. No definition available.
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|